This review focuses on two genetic disorders of metal metabolism, genetic h
emochromatosis and Wilson disease, and on the most common lysosomal storage
disorder, Gaucher disease, for which recombinant enzyme replacement therap
y is available. The discovery of the genes for these disorders has led to a
n explosion of new information about the function of these gene products an
d the identification of other proteins involved in their metabolism. These
discoveries have altered our current diagnostic and therapeutic approaches
to these disorders and have furthered our understanding of disease pathophy
siology. New modalities being developed for future use include cell transpl
ant and genetic replacement therapies. Curr Opin Gastroenterol 2000, 16:219
-230 (C) 2000 Lippincott William & Wilkins, Inc.